Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF

David E. Kandzari; Raymond R. Townsend; George Bakris; Jan Basile; Michael J. Bloch; Debbie L. Cohen; Cara East; Keith C. Ferdinand; Naomi Fisher; Ajay Kirtane; David P. Lee; Gary Puckrein; Florian Rader; Joseph A. Vassalotti; Michael A. Weber; Kerry Willis; Eric Secemsky

doi:10.1002/ccd.29884

Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF

David E. Kandzari
, Raymond R. Townsend
, George Bakris
, Jan Basile
, Michael J. Bloch
, Debbie L. Cohen
, Cara East
, Keith C. Ferdinand
, Naomi Fisher
, Ajay Kirtane
, David P. Lee
, Gary Puckrein
, Florian Rader
, Joseph A. Vassalotti
, Michael A. Weber
, Kerry Willis
, Eric Secemsky

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Original language	English
Pages (from-to)	416-426
Number of pages	11
Journal	Catheterization and Cardiovascular Interventions
Volume	98
Issue number	3
DOIs	https://doi.org/10.1002/ccd.29884
State	Published - Sep 2021
Externally published	Yes

Keywords

blood pressure
cardiovascular risk
device-based hypertension therapies
hypertension
renal denervation

Access to Document

10.1002/ccd.29884

Cite this

Kandzari, D. E., Townsend, R. R., Bakris, G., Basile, J., Bloch, M. J., Cohen, D. L., East, C., Ferdinand, K. C., Fisher, N., Kirtane, A., Lee, D. P., Puckrein, G., Rader, F., Vassalotti, J. A., Weber, M. A., Willis, K., & Secemsky, E. (2021). Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF. Catheterization and Cardiovascular Interventions, 98(3), 416-426. https://doi.org/10.1002/ccd.29884

@article{febed77e241945cda4145afe66fd2ae4,

title = "Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF",

keywords = "blood pressure, cardiovascular risk, device-based hypertension therapies, hypertension, renal denervation",

author = "Kandzari, \{David E.\} and Townsend, \{Raymond R.\} and George Bakris and Jan Basile and Bloch, \{Michael J.\} and Cohen, \{Debbie L.\} and Cara East and Ferdinand, \{Keith C.\} and Naomi Fisher and Ajay Kirtane and Lee, \{David P.\} and Gary Puckrein and Florian Rader and Vassalotti, \{Joseph A.\} and Weber, \{Michael A.\} and Kerry Willis and Eric Secemsky",

note = "Funding Information: George Bakris: Consultant for Merck, Bayer, Vascular Dynamics, KBP Biosciences, Ionis, Alnylam, Astra Zeneca, Quantum Genomics, Horizon, Novo Nordisk; Steering committee of trials supported by Bayer, Vascular Dynamics, Quantum Genomics, Alnylam and Novo Nordisk. Jan Basile: Consultant for Medtronic; Research grants from Eli Lilly, ReCor, and Ablative Solutions; Royalties from UpToDate. Michael J. Bloch: Consultant/Honoraria from Recor, Medtronic, Amgen, Esperion, Janssen, Amarin, and Bristol Meyers Squibb; Research Support from Recor. Debbie L. Cohen: Research support from Medtronic and ReCor. Cara East: Research support from Medtronic. Keith C. Ferdinand: Consultant for Amgen, Novartis, and Medtronic. Naomi Fisher: Consultant for Aktiia; Consultant and research support from Recor Medical. David E. Kandzari: Consulting honoraria from Cardiovascular Systems, Inc, Medtronic. Institutional research/grant support from Ablative Solutions, Boston Scientific, Biotronik, Cardiovascular Systems, Medtronic, Orbus Neich, and Teleflex. Ajay Kirtane: Institutional funding to Columbia University and/or Cardiovascular Research Foundation from Medtronic, Boston Scientific, Abbott Vascular, Abiomed, CSI, CathWorks, Siemens, Philips, ReCor Medical, Neurotronic. In addition to research grants, institutional funding includes fees paid to Columbia University and/or Cardiovascular Research Foundation for consulting and/or speaking engagements in which Dr. Kirtane controlled the content. Personal: Consulting from IMDS; Travel Expenses/Meals from Medtronic, Boston Scientific, Abbott Vascular, Abiomed, CSI, CathWorks, Siemens, Philips, ReCor Medical, Chiesi, OpSens, Zoll, and Regeneron. David P. Lee: Consultant for Medtronic and DeepQure; Research grants from Medtronic and Ablative Solutions. Florian Rader: Consultant for Recor, Medtronic, and MyoKardia. Eric Secemsky: Consulting/Speaking: Abbott, Bayer, BD, Boston Scientific, Cook, CSI, Inari, Janssen, Medtronic, Philips, and VentureMed; Research grants from NIH/NHLBI K23HL150290, Harvard Medical School's Shore Faculty Development Award, AstraZeneca, BD, Boston Scientific, Cook, CSI, Laminate Medical, Medtronic, and Philips. Raymond R. Townsend: Consultant for Medtronic, Axio, Regeneron, Ionis, and IMEDIC; Royalties from UpToDate; Grants from NIH. Joseph A. Vassalotti: Consultant for RenalytixAI, plc. Michael A. Weber: Consultant to Medtronic, ReCor, Ablative Solutions, Johnson \& Johnson, Urovant, and Omron. Kerry Willis and Gary Puckrein have no conflicts to disclose. Funding Information: The present communication represents considerations and consensus views from a roundtable discussion between leaders in hypertension and interventional cardiology. The consensus conference was supported by the National Kidney Foundation and the Society for Cardiovascular Angiography and Interventions; however, the content of this report represents solely the opinions of the consensus committee members. ",

year = "2021",

month = sep,

doi = "10.1002/ccd.29884",

language = "English",

volume = "98",

pages = "416--426",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-1946",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

Kandzari, DE, Townsend, RR, Bakris, G, Basile, J, Bloch, MJ, Cohen, DL, East, C, Ferdinand, KC, Fisher, N, Kirtane, A, Lee, DP, Puckrein, G, Rader, F, Vassalotti, JA, Weber, MA, Willis, K & Secemsky, E 2021, 'Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF', Catheterization and Cardiovascular Interventions, vol. 98, no. 3, pp. 416-426. https://doi.org/10.1002/ccd.29884

TY - JOUR

T1 - Renal denervation in hypertension patients

T2 - Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF

AU - Kandzari, David E.

AU - Townsend, Raymond R.

AU - Bakris, George

AU - Basile, Jan

AU - Bloch, Michael J.

AU - Cohen, Debbie L.

AU - East, Cara

AU - Ferdinand, Keith C.

AU - Fisher, Naomi

AU - Kirtane, Ajay

AU - Lee, David P.

AU - Puckrein, Gary

AU - Rader, Florian

AU - Vassalotti, Joseph A.

AU - Weber, Michael A.

AU - Willis, Kerry

AU - Secemsky, Eric

N1 - Funding Information: George Bakris: Consultant for Merck, Bayer, Vascular Dynamics, KBP Biosciences, Ionis, Alnylam, Astra Zeneca, Quantum Genomics, Horizon, Novo Nordisk; Steering committee of trials supported by Bayer, Vascular Dynamics, Quantum Genomics, Alnylam and Novo Nordisk. Jan Basile: Consultant for Medtronic; Research grants from Eli Lilly, ReCor, and Ablative Solutions; Royalties from UpToDate. Michael J. Bloch: Consultant/Honoraria from Recor, Medtronic, Amgen, Esperion, Janssen, Amarin, and Bristol Meyers Squibb; Research Support from Recor. Debbie L. Cohen: Research support from Medtronic and ReCor. Cara East: Research support from Medtronic. Keith C. Ferdinand: Consultant for Amgen, Novartis, and Medtronic. Naomi Fisher: Consultant for Aktiia; Consultant and research support from Recor Medical. David E. Kandzari: Consulting honoraria from Cardiovascular Systems, Inc, Medtronic. Institutional research/grant support from Ablative Solutions, Boston Scientific, Biotronik, Cardiovascular Systems, Medtronic, Orbus Neich, and Teleflex. Ajay Kirtane: Institutional funding to Columbia University and/or Cardiovascular Research Foundation from Medtronic, Boston Scientific, Abbott Vascular, Abiomed, CSI, CathWorks, Siemens, Philips, ReCor Medical, Neurotronic. In addition to research grants, institutional funding includes fees paid to Columbia University and/or Cardiovascular Research Foundation for consulting and/or speaking engagements in which Dr. Kirtane controlled the content. Personal: Consulting from IMDS; Travel Expenses/Meals from Medtronic, Boston Scientific, Abbott Vascular, Abiomed, CSI, CathWorks, Siemens, Philips, ReCor Medical, Chiesi, OpSens, Zoll, and Regeneron. David P. Lee: Consultant for Medtronic and DeepQure; Research grants from Medtronic and Ablative Solutions. Florian Rader: Consultant for Recor, Medtronic, and MyoKardia. Eric Secemsky: Consulting/Speaking: Abbott, Bayer, BD, Boston Scientific, Cook, CSI, Inari, Janssen, Medtronic, Philips, and VentureMed; Research grants from NIH/NHLBI K23HL150290, Harvard Medical School's Shore Faculty Development Award, AstraZeneca, BD, Boston Scientific, Cook, CSI, Laminate Medical, Medtronic, and Philips. Raymond R. Townsend: Consultant for Medtronic, Axio, Regeneron, Ionis, and IMEDIC; Royalties from UpToDate; Grants from NIH. Joseph A. Vassalotti: Consultant for RenalytixAI, plc. Michael A. Weber: Consultant to Medtronic, ReCor, Ablative Solutions, Johnson & Johnson, Urovant, and Omron. Kerry Willis and Gary Puckrein have no conflicts to disclose. Funding Information: The present communication represents considerations and consensus views from a roundtable discussion between leaders in hypertension and interventional cardiology. The consensus conference was supported by the National Kidney Foundation and the Society for Cardiovascular Angiography and Interventions; however, the content of this report represents solely the opinions of the consensus committee members.

PY - 2021/9

Y1 - 2021/9

KW - blood pressure

KW - cardiovascular risk

KW - device-based hypertension therapies

KW - hypertension

KW - renal denervation

UR - https://www.scopus.com/pages/publications/85111850161

U2 - 10.1002/ccd.29884

DO - 10.1002/ccd.29884

M3 - Article

C2 - 34343406

AN - SCOPUS:85111850161

SN - 1522-1946

VL - 98

SP - 416

EP - 426

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

IS - 3

ER -